The relationship between CCT-3 protein expression and breast cancer clinical features, including age, clinical stage, TNM classification, expression of estrogen receptor, expression of progesterone receptor, and expression of HER2, was analyzed. This evidence concerns the gene ESR1 and breast cancer.